Electroretinography (ERG) and Visual Evoked Potential (VEP) Diopsys, Inc. is the world leader in modern visual electrophysiology medical devices that help eye care professionals analyze the entire visual pathway for visual and neuro-visual disorders. The company provides both Visual Evoked Potential (VEP) and Electroretinography (ERG) vision testing technology. It is this technology that powers Diopsys, Inc.’s medical devices – the Diopsys® NOVA™, Diopsys® ARGOS™, and Diopsys® RETINA PLUS™ ERG and VEP Vision Testing System product series and the Enfant® Pediatric VEP Vision Testing System.
Our patented technology is clinically effective in providing objective, functional information to eye care professionals for the most appropriate and timely treatment of vision disorders. This technology is used for the detection of subclinical vision disorders, decision making when a diagnosis is equivocal/differential, comparative data to monitor treatment success, and objective vision testing in children. ERG and VEP also provide data to help isolate the location of visual pathway abnormalities, monitor progression of disease, and give the physician objective, alternative testing methods when the patient or other test results have limitations. Diopsys vision testing systems have US FDA 510k clearance. In addition, Diopsys vision testing systems have been assessed and certified as meeting the requirements of Directive 93/42/EEC. The company’s devices also carry the CE mark allowing sales in the European Union (EU).
For detailed information on Diopsys contact Greg Shackelford